Table 3 AUD treatment and clinical outcomes, by baseline AUD remission status
From: Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis
|  | No alcohol use at baseline (n = 203) | Ongoing alcohol use at baseline (n = 233) |
|---|---|---|
Alcohol use discussion NOT documented at baseline hepatology visit | 151 (74%) | 125 (54%) |
Alcohol use discussed and documented at baseline hepatology visit | 52 (26%) | 108 (46%) |
AUD treatment | ||
None at baseline or follow up | 169 (83%) | 173 (74%) |
Stopped treatment over follow up | 8 (4%) | 5 (2%) |
Started treatment over follow up | 5 (2%) | 29 (12%) |
Treatment at baseline and follow up | 21 (10%) | 26 (11%) |
Transplant | 29 (14%) | 11 (5%) |
Death | 61 (30%) | 91 (39%) |